Chemohyperthermia with Mitomycin C and COMBAT system in High Risk Non-Muscle Invasive Bladder Cancer patients: Initial experience in a single center

continue reading

Quality of life (QoL), Non Muscle Invasive Bladder Cancer (NMIBC) and Endovesical Treatments: Instillation matters.

continue reading

The role of conductive hyperthermia with mitomycin in High Risk Non Muscle Invasive Bladder Cancer that has failed BCG therapy

continue reading

Hyperthermic intravesical chemotherapy for BCG-unresponsive or BCG ineligible non-muscle invasive bladder cancer patients

continue reading

Global Congress on Bladder Cancer 5-6th October 2017

Combat Medical are exhibiting at the Global Congress on Bladder Cancer- Edinburgh. 4 abstracts will

continue reading

BAUS Annual Scientific Meeting (Glasgow 2017) 26 Jun – 28 Jun 2017

We will once again be attending and exhibiting at the forthcoming annual BAUS Conference in

continue reading

European Society of Hyperthermic Oncology – ESHO Athens-Greece, June 21 – 23, 2017.

We will be attending and exhibiting at the forthcoming ESHO meeting in Athens on 21-23rd

continue reading

ENFURO Congress – Spain

As usage with the COMBAT BRS system grows, more hospitals are beginning to publish and

continue reading

National Urology Congress- Sevilla, Spain LXXXII Congreso Nacional de Urología, Sevilla, 7 al 10 de junio de 2017

It has been a busy time for Combat in Spain, and last week, in partnership

continue reading

National Urology Conference – Pisa, Italy

Combat Medical Ltd recently attended the national meeting in Pisa Italy, during which time, Ms

continue reading